Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

AtlasMedx initiates phase I/II study of AMXI-5001 in advanced malignancies

Aug. 26, 2020

New sphingomyelin phosphodiesterase 3 inhibitors discovered at Johns Hopkins University

Aug. 26, 2020

Foghorn Therapeutics patents PROTACs targeting BRD9

Aug. 26, 2020

New DNA polymerase theta inhibitors discovered at Ideaya Biosciences

Aug. 26, 2020

MMA induces epithelial-to-mesenchymal transition

Aug. 26, 2020

Pivotal phase III INSPIRE study of rigosertib in MDS does not meet primary endpoint

Aug. 25, 2020

New adenosine A2A/A2B receptor antagonists identified at Incyte

Aug. 25, 2020

Orexin receptor type 1 antagonists discovered at Heptares Therapeutics

Aug. 25, 2020

Positive topline data presented from phase III CONTESSA study of tesetaxel

Aug. 25, 2020

Bayer, The Broad Institute describe new PDE3A and/or PDE3B inhibitors

Aug. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...